Prestige Wealth (PWM) Competitors $0.41 -0.03 (-6.82%) Closing price 04/3/2025 03:50 PM EasternExtended Trading$0.41 0.00 (0.00%) As of 04/3/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PWM vs. NRBO, BTCT, SHFS, MCVT, ANY, AIHS, MIGI, GRYP, GREE, and CARVShould you be buying Prestige Wealth stock or one of its competitors? The main competitors of Prestige Wealth include NeuroBo Pharmaceuticals (NRBO), BTC Digital (BTCT), SHF (SHFS), Mill City Ventures III (MCVT), Sphere 3D (ANY), Senmiao Technology (AIHS), Mawson Infrastructure Group (MIGI), Gryphon Digital Mining (GRYP), Greenidge Generation (GREE), and Carver Bancorp (CARV). These companies are all part of the "banking" industry. Prestige Wealth vs. NeuroBo Pharmaceuticals BTC Digital SHF Mill City Ventures III Sphere 3D Senmiao Technology Mawson Infrastructure Group Gryphon Digital Mining Greenidge Generation Carver Bancorp Prestige Wealth (NASDAQ:PWM) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, risk, profitability, analyst recommendations, valuation and media sentiment. Is PWM or NRBO more profitable? Prestige Wealth's return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Prestige WealthN/A N/A N/A NeuroBo Pharmaceuticals N/A -189.12%-122.31% Does the MarketBeat Community favor PWM or NRBO? NeuroBo Pharmaceuticals received 27 more outperform votes than Prestige Wealth when rated by MarketBeat users. CompanyUnderperformOutperformPrestige WealthN/AN/ANeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% Which has more volatility and risk, PWM or NRBO? Prestige Wealth has a beta of 3.2, suggesting that its share price is 220% more volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, suggesting that its share price is 126% less volatile than the S&P 500. Do analysts prefer PWM or NRBO? NeuroBo Pharmaceuticals has a consensus price target of $10.00, indicating a potential upside of 549.35%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NeuroBo Pharmaceuticals is more favorable than Prestige Wealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prestige Wealth 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings & valuation, PWM or NRBO? Prestige Wealth has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrestige Wealth$639.91K5.66-$6.88MN/AN/ANeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A Does the media refer more to PWM or NRBO? In the previous week, Prestige Wealth had 2 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 2 mentions for Prestige Wealth and 0 mentions for NeuroBo Pharmaceuticals. Prestige Wealth's average media sentiment score of 1.39 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Prestige Wealth is being referred to more favorably in the media. Company Overall Sentiment Prestige Wealth Positive NeuroBo Pharmaceuticals Neutral Do insiders & institutionals have more ownership in PWM or NRBO? 7.7% of Prestige Wealth shares are owned by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are owned by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryPrestige Wealth beats NeuroBo Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Remove Ads Get Prestige Wealth News Delivered to You Automatically Sign up to receive the latest news and ratings for PWM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWM vs. The Competition Export to ExcelMetricPrestige WealthNondepository credit institutions IndustryFinance SectorNASDAQ ExchangeMarket Cap$3.62M$6.88B$11.01B$7.50BDividend YieldN/A4.17%5.42%4.04%P/E RatioN/A15.8621.9818.08Price / Sales5.668.3925.2886.83Price / CashN/A42.1517.6234.64Price / Book1.212.022.663.99Net Income-$6.88M$524.31M$1.03B$247.18M7 Day Performance-11.35%-5.14%-2.52%-4.25%1 Month Performance-25.72%-10.57%496.68%-6.87%1 Year Performance-70.50%3.33%533.49%-3.73% Prestige Wealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWMPrestige Wealth0.3943 of 5 stars$0.41-6.8%N/A-71.7%$3.62M$639,912.000.004Positive NewsNRBONeuroBo Pharmaceuticals1.2168 of 5 stars$1.58+1.0%$10.00+534.9%-60.4%$13.57MN/A0.0010Gap UpBTCTBTC Digital0.3748 of 5 stars$4.02+1.0%N/A+10.6%$13.25M$8.48M0.0016SHFSSHF1.2782 of 5 stars$4.29-3.6%N/A-86.2%$11.94M$22.21M25.243Upcoming EarningsMCVTMill City Ventures III0.7439 of 5 stars$1.60-3.9%N/A-39.1%$10.18M$3.57M-22.782Gap DownANYSphere 3D2.1183 of 5 stars$0.40-4.9%$3.00+652.8%-61.7%$10.14M$21.66M-0.5020Earnings ReportAnalyst ForecastGap DownAIHSSenmiao TechnologyN/A$0.91+0.3%N/A-1.1%$9.52M$5.88M-2.83150Positive NewsGap DownMIGIMawson Infrastructure Group1.7942 of 5 stars$0.50-1.5%$2.00+301.9%-67.7%$9.31M$58.22M-0.1640Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageGap UpHigh Trading VolumeGRYPGryphon Digital Mining1.3064 of 5 stars$0.17+3.2%N/A-87.9%$8.81M$7.69M0.00200Earnings ReportAnalyst ForecastAnalyst RevisionGap UpGREEGreenidge Generation3.5622 of 5 stars$0.73-10.9%$4.00+445.0%-77.5%$8.19M$64.38M0.00680Upcoming EarningsCARVCarver Bancorp0.5615 of 5 stars$1.41+1.4%N/A-12.1%$7.10M$24.59M-0.73110Analyst ForecastNews Coverage Remove Ads Related Companies and Tools Related Companies NRBO Alternatives BTCT Alternatives SHFS Alternatives MCVT Alternatives ANY Alternatives AIHS Alternatives MIGI Alternatives GRYP Alternatives GREE Alternatives CARV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PWM) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Wealth Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Wealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.